Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Laura Burgers"'
Publikováno v:
European Law Open, Vol 3, Pp 90-110 (2024)
Belarus willingly uses migrants as a tool for political pressure, sending them into forests bordering the EU. This prompted Poland to secure its territory with additional troops and, first, to build a razor wire fence, and, second, to build an entire
Externí odkaz:
https://doaj.org/article/2cbd3912787d4f529314bf7ca3fa9668
Autor:
Nigel Armstrong, Laura Burgers, Sohan Deshpande, Maiwenn Al, Rob Riemsma, SR Vallabhaneni, Peter Holt, Johan Severens, Jos Kleijnen
Publikováno v:
Health Technology Assessment, Vol 18, Iss 70 (2014)
Background: Patients with large abdominal aortic aneurysms (AAAs) are usually offered reparative treatment given the high mortality risk. There is uncertainty about how to treat juxtarenal AAAs (JRAAAs) or thoracoabdominal aortic aneurysms (TAAAs). E
Externí odkaz:
https://doaj.org/article/ab8afe61e0154ce38d5b6a81b3b2db4d
Autor:
Penny Whiting, Maiwenn Al, Laura Burgers, Marie Westwood, Steve Ryder, Martine Hoogendoorn, Nigel Armstrong, Alex Allen, Hans Severens, Jos Kleijnen
Publikováno v:
Health Technology Assessment, Vol 18, Iss 18 (2014)
Background: Ivacaftor (Kalydeco®, Vertex Pharmaceuticals) is the first of a new class of drugs that target the underlying protein defect in cystic fibrosis (CF). It is aimed at patients with the G551D (glycine to aspartate change in nucleotide 17
Externí odkaz:
https://doaj.org/article/3952a09276cd483f886d8fadccd7169f
Autor:
Laura Burgers
Publikováno v:
Transnational Environmental Law, 11(2), 419-431. Cambridge University Press
This invited response commentary engages with Benoit Mayer's case comment, published in this issue of Transnational Environmental Law, on the recent landmark decision by the District Court of The Hague (The Netherlands) of May 2021 in Milieudefensie
Autor:
Laura Burgers, Kinanya Pijl
Publikováno v:
Erasmus law review, 2022(3), 212-228
The question is no longer whether we should move to an environmentally sustainable way of living; rather, the question is – how are we supposed to do that? Katharina Pistor’s seminal book The Code of Capital pointed out that our current form of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73397e92d5e14ea8da87e55bcb1bac97
https://dare.uva.nl/personal/pure/en/publications/collective-ownership-and-representation-in-a-sustainable-city(d3c05454-0e5d-462e-8c8d-91c92791d30d).html
https://dare.uva.nl/personal/pure/en/publications/collective-ownership-and-representation-in-a-sustainable-city(d3c05454-0e5d-462e-8c8d-91c92791d30d).html
Autor:
Wichor M. Bramer, Frederick W. Thielen, Silvia M. A. A. Evers, Jos Kleijnen, H.J.M. Majoie, Ghislaine A. P. G. van Mastrigt, Laura Burgers
Publikováno v:
Expert review of pharmacoeconomics & outcomes research, 16(6), 1-17. Taylor & Francis Ltd
Expert Review of Pharmacoeconomics & Outcomes Research, 16(6), 705-721. Routledge/Taylor & Francis Group
Expert Review of Pharmacoeconomics & Outcomes Research, 16(6), 705-721. Routledge/Taylor & Francis Group
Introduction: This article is part of the series “How to prepare a systematic review of economic evaluations (EES) for informing evidence-based healthcare decisions”, in which a five-step approach is proposed. Areas covered: This paper focuses on
Autor:
Simon Walker, Maiwenn Al, William K. Redekop, Johan L. Severens, Laura Burgers, Nigel Armstrong, Claire Rothery, Marie Westwood, Stefan K. Lhachimi
Publikováno v:
European Journal of Health Economics (HEPAC), 1-12. Springer-Verlag
STARTPAGE=1;ENDPAGE=12;ISSN=1618-7601;TITLE=European Journal of Health Economics (HEPAC)
STARTPAGE=1;ENDPAGE=12;ISSN=1618-7601;TITLE=European Journal of Health Economics (HEPAC)
New generation dual-source coronary CT (NGCCT) scanners with more than 64 slices were evaluated for patients with (known) or suspected of coronary artery disease (CAD) who are difficult to image: obese, coronary calcium score > 400, arrhythmias, prev
Autor:
Johannes Waltenberger, Elizabeth A. McClellan, Laura Burgers, Joop Jukema, Imo E. Hoefer, A. C. Stubbs, Marieke A. Hillaert, Nico H.J. Pijls, Sebastiaan Horsman, Gerard Pasterkamp, Johan L. Severens, William K. Redekop
Publikováno v:
Netherlands Heart Journal, 24, 110-119. Bohn Stafleu van Loghum
Netherlands Heart Journal, 24(2), 110-119. Bohn Stafleu van Loghum
Netherlands Heart Journal, 24(2), 110. Bohn Stafleu van Loghum
Netherlands Heart Journal
Netherlands Heart Journal, 24(2), 110-119. Bohn Stafleu van Loghum
Netherlands Heart Journal, 24(2), 110. Bohn Stafleu van Loghum
Netherlands Heart Journal
Aim Variations in treatment are the result of differences in demographic and clinical factors (e.g. anatomy), but physician and hospital factors may also contribute to treatment variation. The choice of treatment is considered important since it coul
Publikováno v:
International Journal of Cardiology, 176(3), 980-987. Elsevier Ireland Ltd
Background The 2012 European guidelines recommend statins for intermediate-risk individuals with elevated cholesterol levels. Improved discrimination of intermediate-risk individuals is needed to prevent both cardiovascular disease (CVD) and statin s